Whitehawk Therapeutics, Inc. (WHWK) Insider Trading -- Recent Executive & Director Transactions

5 insiders reported 25 Form 4 transactions for Whitehawk Therapeutics, Inc. (WHWK) over the past 18 months (most recent 2026-05-18). Recent activity: Castelein Caley (Director) Buy 255,102 shares, Giacobello Scott M. (CHIEF FINANCIAL OFFICER) Buy 38,265 shares, BALL BRYAN (See remarks) Buy 51,020 shares, Dugan Margaret (Chief Medical Officer) Buy 19,132 shares, Lennon David James (CHIEF EXECUTIVE OFFICER) Buy 51,021 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-05-18Castelein CaleyDirectorBuy255,102$1,000,000
2026-05-18Giacobello Scott M.CHIEF FINANCIAL OFFICERBuy38,265$149,999
2026-05-18BALL BRYANSee remarksBuy51,020$199,998
2026-05-18Dugan MargaretChief Medical OfficerBuy19,132$74,997
2026-05-18Lennon David JamesCHIEF EXECUTIVE OFFICERBuy51,021$200,002
2026-04-17Giacobello Scott M.CHIEF FINANCIAL OFFICERSell77,000$297,220
2026-04-17Giacobello Scott M.CHIEF FINANCIAL OFFICERSell141,600$584,808
2026-04-15BALL BRYANSee remarksSell26,389$91,306
2026-04-15BALL BRYANSee remarksSell92,460$336,554
2026-04-13BALL BRYANSee remarksSell50,000$178,500
2026-04-13BALL BRYANSee remarksSell6,596$22,624
2026-04-10Lennon David JamesCHIEF EXECUTIVE OFFICERSell14,500$49,010
2026-04-08Lennon David JamesCHIEF EXECUTIVE OFFICERSell102,395$359,406
2026-04-08Lennon David JamesCHIEF EXECUTIVE OFFICERSell94,087$322,718
2026-04-08Lennon David JamesCHIEF EXECUTIVE OFFICERSell63,945$217,413
2026-04-03Giacobello Scott M.CHIEF FINANCIAL OFFICERBuy473,902$0
2026-04-03BALL BRYANSee remarksBuy366,532$0
2026-04-03Lennon David JamesCHIEF EXECUTIVE OFFICERBuy775,828$0
2026-04-03Lennon David JamesCHIEF EXECUTIVE OFFICERSell26,858$93,466
2026-03-10Giacobello Scott M.CHIEF FINANCIAL OFFICERBuy6,750$0
2026-03-10Giacobello Scott M.CHIEF FINANCIAL OFFICERSell2,594$8,586
2026-03-10BALL BRYANSee remarksBuy5,000$0
2026-03-10BALL BRYANSee remarksSell1,834$6,071
2026-03-10Lennon David JamesCHIEF EXECUTIVE OFFICERBuy16,250$0
2026-03-10Lennon David JamesCHIEF EXECUTIVE OFFICERSell5,100$16,881

Source: SEC Form 4 filings · as of 2026-05-18